Mohamadian M, Fallah H, Ghofrani-Jahromi Z, Rahimi-Danesh M, Shokouhi Qare Saadlou M, Vaseghi S
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(7):1339-1359.
PMID: 36843130
DOI: 10.1007/s00210-023-02437-1.
Shallie P, Akpan H, Adefule A, Fakoya D, Fagbohun T
J Pharm Bioallied Sci. 2011; 2(2):113-7.
PMID: 21814443
PMC: 3147093.
DOI: 10.4103/0975-7406.67016.
Dziedzicka-Wasylewska M, Mackowiak M, Fijat K, Wedzony K
J Neural Transm (Vienna). 1996; 103(7):765-76.
PMID: 8872863
DOI: 10.1007/BF01273357.
Baptista T, Teneud L, Contreras Q, Burguera J, Burguera M, Hernandez L
J Neural Transm Gen Sect. 1993; 94(2):75-89.
PMID: 7509157
DOI: 10.1007/BF01245002.
Ehrlich B, Diamond J
J Membr Biol. 1980; 52(3):187-200.
PMID: 6991708
DOI: 10.1007/BF01869189.
Clinical and neuropathological aspects of long-term damage to the central nervous system after lithium medication.
PEIFFER J
Arch Psychiatr Nervenkr (1970). 1981; 231(1):41-60.
PMID: 6797383
DOI: 10.1007/BF00342829.
The effect of long-term concurrent administration of chlorpromazine and lithium on the striatal and frontal cortical dopamine metabolism in rats.
Eroglu L, Hizal A, KOYUNCUOGLU H
Psychopharmacology (Berl). 1981; 73(1):84-6.
PMID: 6785796
DOI: 10.1007/BF00431108.
Comparison of acute and chronic lithium treatment on 3H-norepinephrine uptake by rat brain slices.
Cameron O, Smith C
Psychopharmacology (Berl). 1980; 67(1):81-5.
PMID: 6768082
DOI: 10.1007/BF00427599.
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
Reches A, Jackson-Lewis V, Fahn S
Psychopharmacology (Berl). 1984; 82(4):330-4.
PMID: 6427824
DOI: 10.1007/BF00427680.
Effect of lithium on central metabolism of 5-hydroxytryptamine.
Poitou P, Guerinot F, Bohuon C
Psychopharmacologia. 1974; 38(1):75-80.
PMID: 4851658
DOI: 10.1007/BF00421289.
Effect of chronic lithium treatment on monoamine metabolism in rat brain.
Schubert J
Psychopharmacologia. 1973; 32(3):301-11.
PMID: 4762238
DOI: 10.1007/BF00422153.
Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children.
Campbell M, Fish B, Korein J, Shapiro T, Collins P, Koh C
J Autism Child Schizophr. 1972; 2(3):234-63.
PMID: 4567547
DOI: 10.1007/BF01537617.
Chronic lithium: desensitization of autoreceptors mediating serotonin release.
Wang H, Friedman E
Psychopharmacology (Berl). 1988; 94(3):312-4.
PMID: 3128806
DOI: 10.1007/BF00174681.
Lithium dampens neurotransmitter response in smooth muscle: relevance to action in affective illness.
Menkes H, Baraban J, FREED A, Snyder S
Proc Natl Acad Sci U S A. 1986; 83(15):5727-30.
PMID: 2874555
PMC: 386362.
DOI: 10.1073/pnas.83.15.5727.
Striatal dopamine and motor activity changes observed shortly after lithium administration.
Otero Losada M, Rubio M
Naunyn Schmiedebergs Arch Pharmacol. 1985; 330(3):169-74.
PMID: 2865683
DOI: 10.1007/BF00572429.
The effect of short-term lithium administration on noradrenaline metabolism in the limbic forebrain and hemispheres of rats.
Berggren U
J Neural Transm. 1988; 73(1):71-5.
PMID: 2841421
DOI: 10.1007/BF01244624.
Effect of lithium administration on rat brain 5-hydroxyindole levels in a possible animal model for mania.
Vale A, Ratcliffe F
Psychopharmacology (Berl). 1987; 91(3):352-5.
PMID: 2436249
DOI: 10.1007/BF00518190.
Lithium and serotonin function: implications for the serotonin hypothesis of depression.
Price L, Charney D, Delgado P, Heninger G
Psychopharmacology (Berl). 1990; 100(1):3-12.
PMID: 2404294
DOI: 10.1007/BF02245781.
The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients.
Fyro B, Petterson U, Sedvall G
Psychopharmacologia. 1975; 44(1):99-103.
PMID: 1105629
DOI: 10.1007/BF00421192.
The effect of lithium on the increase in forebrain 5-hydroxyindoleacetic acid produced by raphe stimulation.
Collard K
Br J Pharmacol. 1978; 62(1):137-42.
PMID: 620093
PMC: 1667792.
DOI: 10.1111/j.1476-5381.1978.tb07016.x.
